Cellosaurus WIL2 MTI-TG (CVCL_A6HS)
| Cell line name | WIL2 MTI-TG |
|---|---|
| Synonyms | MTI-TG |
| Accession | CVCL_A6HS |
| Resource Identification Initiative | To cite this cell line use: WIL2 MTI-TG (RRID:CVCL_A6HS) |
| Comments | Population: Caucasian. Selected for resistance to: ChEBI; CHEBI_44081; 6-methylthioinosine (6-methylmercaptopurine riboside). Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG). Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE). Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV). Derived from site: In situ; Spleen; UBERON=UBERON_0002106. Cell type: B-cell; CL=CL_0000236. |
| Sequence variations |
|
| Disease | Hereditary spherocytosis (NCIt: C97074) Hereditary spherocytosis (ORDO: Orphanet_822) |
| Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) |
| Hierarchy | Parent: CVCL_A6HR (WIL2 MTIr-107) |
| Sex of cell | Male |
| Age at sampling | 5Y |
| Category | Transformed cell line |
| Publications | PubMed=197600; DOI=10.1126/science.197600 PubMed=893394; DOI=10.1016/S0021-9258(17)40020-2 |
| Cross-references | |
| Encyclopedic resources | Wikidata; Q107117458 |
| Entry history | |
| Entry creation | 20-May-2021 |
| Last entry update | 10-Apr-2025 |
| Version number | 6 |